📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

TNAP limits TGF-ß-dependent cardiac and skeletal muscle fibrosis by inactivating SMAD2/3 transcription factors (2019)

First Author: Arnò B

Attributed to: Cell mediated gene therapy for muscular dystrophy: steps towards clinical efficacy. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/655332

Publication URI: http://dx.doi.org/10.1101/655332

Type: Preprint